University of Thessaly (UTH)
Ο ρόλος των ενδοκυττάριων σηματοδοτικών μηχανισμών σε ασθενείς με ιογενείς ηπατίτιδες
Abstract
dc:descriptionInnate and adaptive immune responses against HBV have been shown to play a pivotal role in the control of viral replication as well as in the causation of liver damage. Studies in transgenic mice and human cell lines have shown that during HBV infection several intracellular signaling pathways, including p38 MAPK, are involved in cytokine production and T-cell differentiation.The aim of this study was to investigate the role of p38 MAPK signaling pathway in different phases of the natural history of chronic HBV infection. Thirteen patients with chronic HBV infection were studied. Ten patients had chronic active hepatitis and 3 were inactive carriers of HBV. Patients with chronic active hepatitis were studied before antiviral treatment and at the time of virological response (5 were treated with nucleos(t)ide analogues (NA) and 5 were treated with Peg-IFN-a). Three healthy individuals were studied as controls. Cryopreserved peripheral blood mononuclear cells (PBMCs) were used to determine: a) phosphorylation of p38 MAPK (p-p38) in PBMCs by flow cytometry after incubation with arsenite, PMA and ionomycin and combination of rhIL-12 + rhIL-2 and rhIL-12 + rhIL-18 for 30, 60, 120 and 240 min and b) IFN-γ production from PBMCs after culture with rhIL-12 + rhIL-2 and rhIL-12 + rhIL-18 in the presence or absence of the p38 MAPK inhibitor, SB203580 with ELISA and ELISpot. Also expression of intracellular IFN-γ was estimated by flow cytometry after incubation with PMA and ionomycin. Both patients with active hepatitis B and inactive carriers had significantly higher percentages of p-p38 MAPK positive PBMCs compared to healthy donors. Inactive carriers had the highest percentages of p-p38 positive PBMCs amongst the 3 groups. Patients receiving NA and 2 out of the 5 patients treated with PEG-IFN-a demonstrated reduced percentages of p-p38 MAPK positive PBMCs at the time of virological response compared to those observed before treatment. Similar results were obtained in PBMCs and T -cell subpopulations, especially in CD3+ (T cells) and CD56- (non-NK cells) independent of the stimulus used.Patients with chronic hepatitis B had higher IFN-γ concentrations compared to healthy controls as demonstrated both in ELISA and ELISpot experiments. Similarly, intracellular IFN-γ expression assessed by flow cytometry was higher in patients with active hepatitis B infection compared to healthy controls. Chronic hepatitis B patients tended to have higher IFN-γ concentrations at the time of virological response compared to those observed before treatment. Pharmacological Inhibition of p38 MAPK with SB203580 resulted in reduction of IFN-γ production at all time points in all studied groups. These findings indicate that IFN-γ production/expression correlates with activation of the p38 MAPK intracellular signaling pathway in patients with chronic hepatitis B virus infection. In conclusion, our study demonstrates for the first time the pivotal role of p38 MAPK signaling pathway in the immune responses during chronic HBV infection.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Bakarozi, Maria
- Μπακαρόζη, Μαρία
Subjects
dc:subject × 8Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/35779